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Bordetella pertussis is a causative agent of whoop-
ing cough (pertussis) in humans (Mattoo and 
Cherry, 2005). Recent studies suggest that 48.5 
million people suffer from pertussis per year, 
with as many as 295,000 deaths worldwide 
(Mattoo and Cherry, 2005). Although wide-
scale vaccination has been performed in many 
countries, major concerns exist about pertussis 
as a reemerging infectious disease (Gzyl et al., 
2001; King et al., 2001; He et al., 2003; Raguckas 
et al., 2007). For this reason, the identifica-
tion and characterization of new virulence fac-
tors as potential protective antigens is critical 
for the development of more effective and   
longer-acting vaccines. Possible candidates for 
such protective antigens include the compo-
nent proteins of the type III secretion system 
(T3SS), a protein transport device composed of 
two distinct portions: (1) a cylindrical basal 
body that spans the outer and inner membranes 
of the bacterium and (2) a needle-like structure 
that protrudes from the bacterial outer mem-
brane and functions as an injector of bacterial 
proteins (called effectors) into the host cells 
(Galán and Wolf-Watz, 2006).
Many  Gram-negative  bacterial  pathogens 
exploit T3SS to deliver effectors into host cells, 
thereby altering the physiological functions of 
the infected cells (Finlay and Cossart, 1997). 
T3SSs are involved in establishing disease pro-
cesses, and the virulence of pathogens can be 
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The inflammatory response is one of several host alert mechanisms that recruit neutrophils 
from the circulation to the area of infection. We demonstrate that Bordetella, a bacterial 
pathogen, exploits an antiinflammatory cytokine, interleukin-10 (IL-10), to evade the host 
immune system. We identified a Bordetella effector, BopN, that is translocated into the 
host cell via the type III secretion system, where it induces enhanced production of IL-10. 
Interestingly, the BopN effector translocates itself into the nucleus and is involved in the  
down-regulation of mitogen-activated protein kinases. Using pharmacological blockade,  
we demonstrated that BopN-induced IL-10 production is mediated, at least in part, by its 
ability to block the extracellular signal-regulated kinase pathway. We also showed that 
BopN blocks nuclear translocation of nuclear factor B p65 (NF-Bp65) but, in contrast, 
promotes nuclear translocation of NF-Bp50. A BopN-deficient strain was unable to 
induce IL-10 production in mice, resulting in the elimination of bacteria via neutrophil 
infiltration into the pulmonary alveoli. Furthermore, IL-10–deficient mice effectively 
eliminated wild-type as well as BopN mutant bacteria. Thus, Bordetella exploits BopN as  
a stealth strategy to shut off the host inflammatory reaction. These results explain the  
ability of Bordetella species to avoid induction of the inflammatory response.
© 2009 Nagamatsu et al.  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.jem.org/misc/terms.shtml). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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bacterial effector is a Bordetella strategy used to escape the 
host immune system.
RESULTS
The BopN effector is involved in the up-regulation of IL-10
To determine whether the Bordetella type III effectors are in-
volved in the up-regulation of IL-10, we established an in vitro 
model of infection based on a DC cell line (DC2.4). This model 
mimics DCs expressed in the lower respiratory tract and allows 
detection of IL-10 mRNA; the expression of IL-10 is modu-
lated by Bordetella infection in a T3SS-dependent manner.
DC2.4 cells were infected with WT B. bronchiseptica or its 
isogenic  derivatives,  the  BopC  mutant  (BopC)  and  the 
BopN mutant (BopN), for 60 min. The level of IL-10 
mRNA was then measured by quantitative real-time PCR 
(qRT-PCR; Fig. 1 A). A significantly higher level of IL-10 
mRNA was produced in cells infected with WT or BopC 
compared with BopN or a T3SS mutant (T3SS) strain. 
The up-regulation of IL-10 was restored in cells infected 
with  BopN  complemented  with  a  WT  bopN  clone 
(BopN/pBopN), indicating that BopN, but not BopC, is 
involved in IL-10 up-regulation. It is assumed that DC2.4 
cells  have  the  ability  to  uptake  bacteria  and  the  resulting 
phagocytosis event triggers various host-cell signaling path-
ways.  To  investigate  the  involvement  of  phagocytosis  in   
IL-10 up-regulation, we treated DC2.4 cells with cytochalasin 
D, a fungal metabolite that inhibits phagocytosis (Fig. 1 B). 
The level of IL-10 mRNA in DC2.4 cells infected with WT 
or BopN was not affected by treatment with cytochalasin 
D. Although the level of IL-10 mRNA in DC2.4 cells in-
fected with T3SS appears to be reduced in the presence of 
cytochalasin D, no significant difference in the induction of 
IL-10 was found between BopN and T3SS in the pres-
ence  or  absence  of  cytochalasin  D.  Similar  results  were   
obtained  using  Bordetella  infection  of  BM-derived  DCs   
(BMDCs), and the level of IL-10 mRNA was significantly 
reduced after infection with BopN as well as T3SS rela-
tive to WT (Fig. 1 C). We also determined the amount of 
IL-10 by ELISA (Fig. 1 D), and IL-10 production was signif-
icantly reduced after infection with BopN as well as T3SS 
relative to WT. Collectively, these results suggest that the 
IL-10 up-regulation depends on BopN function and is inde-
pendent of phagocytosis.
BopN is an essential virulence factor
Our in vitro study demonstrated that Bordetella BopN activates 
the expression of the antiinflammatory cytokine IL-10. This 
suggested that Bordetella may establish persistent colonization 
and exert full virulence by perturbation of the inflammatory 
response. Therefore, we investigated BopN function in vivo. 
C57BL/6J mice were infected intranasally with WT or 
BopN B. bronchiseptica (Fig. 2, A and B). Although all mice 
infected with WT (5 × 106 bacteria) succumbed by day 5 
(Fig. 2 A), all mice infected with BopN or T3SS survived, 
indicating that the BopN effector is an essential virulence factor. 
Next, we used a lower dose (5 × 105 bacteria) to mimic   
greatly reduced in T3SS-deficient strains (Abe et al., 1998). 
Although B. pertussis infection is highly specific to humans, 
B. bronchiseptica is a broad host range pathogen that causes 
kennel cough in dogs, atrophic rhinitis in swine, snuffles in 
rabbits, and bronchopneumonia in guinea pigs (Goodnow, 
1980; Foley et al., 2002). B. bronchiseptica is the evolutionary 
progenitor of B. pertussis and B. parapertussis, and many viru-
lence factors and effectors delivered by the T3SS are highly 
conserved among these three strains (Fauconnier et al., 2001). 
For these reasons, B. bronchiseptica has been used as a model 
of B. pertussis. In Bordetella, T3SS as well as adherence factors 
and toxins are positively regulated by a two-component reg-
ulatory system composed of BvgA and BvgS (Stibitz et al., 
1989). Thus, activation of the BvgA/BvgS system triggers 
the bacteria to enter the virulent phase. Five type III– 
secreted proteins—BopB, BopC (also referred to as BteA), 
BopD, BopN, and Bsp22—have been identified in Bordetella 
(Yuk et al., 2000; Kuwae et al., 2003, 2006; Nogawa et al., 
2004; Panina  et  al.,  2005).  We  have  demonstrated  that 
BopB and BopD make a complex and form translocation 
pores  on  the  host  membrane  as  a  conduit  of  effectors   
(Kuwae et al., 2003; Nogawa et al., 2004). Bsp22 poly-
merizes to form a flexible filamentous structure at the tip of the 
needle structure and associates with the pore component 
BopD (Medhekar et al., 2009). The size of the outer diame-
ter and the shape of the Bsp22-mediated filament are similar 
to those of the enteropathogenic Escherichia coli EspA sheath–
like structure that is thought to facilitate the ability of the 
bacteria  to  traverse  the  mucus  layer  and  the  glycocalyx   
of the intestinal epithelium (Sekiya et al., 2001). The Bsp22-
derived filament may have a similar function in establishing 
the T3SS-dependent persistent colonization of the respira-
tory tract. Finally, the Bordetella BopC/BteA effector can be 
translocated into the host cells via the T3SS and the BopB/
BopD-mediated translocation pore, and induces necrotic cell 
death in mammalian cell lines (Panina et al., 2005; Kuwae   
et al., 2006).
In vivo studies using B. bronchiseptica have demonstrated 
that the T3SS plays a role in the persistent bacterial coloni-
zation of the lower respiratory tract by modulating host   
immune responses; B. bronchiseptica infection alters DC matu-
ration and enhances the production of the antiinflammatory 
cytokine IL-10 (Skinner et al., 2004; Skinner et al., 2005; 
Pilione and Harvill, 2006), thereby inhibiting production of 
proinflammatory cytokines such as IFN-. Furthermore, B. 
bronchiseptica colonization in IL-10/ mice is significantly 
reduced compared with that in WT mice (Skinner et al., 
2005; Pilione and Harvill, 2006). In contrast, IFN-/ mice 
exhibit defective clearance of B. bronchiseptica compared with 
WT mice (Pilione and Harvill, 2006). These results suggest 
that Bordetella actively enhances the production of the immuno-
suppressive cytokine IL-10 as a survival strategy, using cer-
tain unknown type III effectors.
In this study, we have identified BopN as the effector   
involved in the up-regulation of IL-10. We report that the 
IL-10–mediated  antiinflammatory  response  triggered  by  a JEM VOL. 206, December 21, 2009 
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fibrin deposition in the pulmonary alveoli only in mice   
infected with the WT strain (Fig. S1). Peribronchiolar edema 
formation (unpublished data) and infiltration of neutrophils 
and macrophages into the pulmonary alveoli were observed 
in mice infected with WT, bopN, and T3SS. However, 
the degree of neutrophil infiltration into the pulmonary alve-
oli after BopN infection was significantly higher than the 
infiltration after WT or T3SS infection (WT, 4 ± 2 cells/ 
100 µm2; bopN, 52 ± 8 cells/100 µm2; T3SS, 2 ± 1 cells/ 
100 µm2; and uninfected, 1 ± 1 cells/100 µm2; Fig. 2 G). A 
small number of neutrophils was observed in the bronchiolus 
upon WT infection, whereas a large number of aggregated 
neutrophils was observed in the bronchiolus upon BopN 
infection. In contrast, mice infected with T3SS had the 
appearance of uninfected controls with no histological le-
sions. These results suggest that BopN counteracts the host 
inflammatory responses by suppressing neutrophil infiltration 
into the pulmonary alveoli and bronchiolus, even though the 
total number of neutrophils in the lung was similar between 
WT and BopN infection (Fig. 2 C).
Bordetella alters the tracheal microenvironment
To determine the mechanism by which BopN contributes to 
bacterial colonization in the trachea, mice infected with WT 
or BopN B. bronchiseptica were sacrificed 2 d after infection, 
and tracheal sections were examined by scanning electron 
microscopy (Fig. 3, A and B). Upon WT B. bronchiseptica  
infection, bacteria were detected in the trachea (Fig. 3 A,   
arrowheads) but neither cell-surface damage nor areas of 
damaged cilia were observed. To our surprise, even though 
Bordetella virulence was greatly reduced upon loss of BopN 
function (Fig. 2), we observed cell-surface disruption, an   
persistent colonization by Bordetella (Fig. 2 B). Upon infection 
with WT, the bacterial number in the lung continued to   
increase for 5 d, and WT bacteria appeared to establish persistent 
colonization. In contrast, the number of bacteria in the lung 
did not increase upon infection with either BopN or T3SS 
and  was  significantly  decreased  after  14  d,  indicating  that 
BopN is involved in persistent colonization.
Because neutrophils and macrophages are involved in the 
elimination of bacteria at an early phase of infection, cells 
from the lungs of mice infected with Bordetella were isolated 
and analyzed by FACS with anti–Gr-1, anti-CD11b, and 
anti-CD11c antibodies (Fig. 2, C and D). The lungs of mice 
infected with WT, BopN, and T3SS contained a large 
number of Gr-1+/CD11b+ cells (neutrophils) at 2 d after in-
fection, but the neutrophil number was greatly reduced by 
5 and 8 d (Fig. 2 C). In contrast, at 2 d after infection, the total 
number of CD11c/CD11b+ cells (macrophages) in WT-
  infected lungs was lower than the number of macrophages in 
lungs infected with BopN or T3SS (Fig. 2 D). By 5 and 
8 d after infection, the numbers of macrophages in the lungs 
were approximately equal regardless of the strain of Bordetella. 
To further investigate the relative neutrophil or macrophage 
number involved in bacterial elimination, the total numbers 
of neutrophils (Fig. 2 C) or macrophages (Fig. 2 D) in the 
lung were normalized by the bacterial number obtained in 
Fig. 2 B. The relative number of neutrophils or macrophages 
in the lung was very different between WT versus BopN or 
T3SS infection (Fig. 2, E and F).
Lung sections were obtained from mice 2 d after infec-
tion with B. bronchiseptica WT, bopN, and T3SS (5 × 105 
bacteria), and stained with hematoxylin and eosin (H&E; 
Fig. 2 G). Histological analysis showed edema formation and 
Figure 1.  BopN is involved in the up-regulation of IL-10. (A and B) DC2.4 cells were cultured in the absence (A) or presence (B) of 1 µM cytochala-
sin D (Cyto.D) for 30 min, and then infected with B. bronchiseptica WT, BopN effector mutant (BopN), BopN mutant complemented with a WT bopN 
clone (BopN/pBopN), BopC effector mutant (BopC), or T3SS mutant (T3SS). After 60 min, total RNA was prepared and levels of IL-10 mRNA were 
assessed by real-time PCR using the comparative cycle threshold method. (C) BMDCs were infected with the indicated strains. After 60 min, total RNA 
was prepared and amounts of IL-10 mRNAs were assessed by real-time PCR. The values in A–C were normalized to the internal control -actin and  
calculated in arbitrary units set to a value of 1 for uninfected cells. (D) BMDCs were infected with the indicated strains. After 60 min, the amount of  
IL-10 in the culture medium was determined by ELISA. The values are means ± SE from three independent experiments. *, P < 0.05.3076 Bordetella immune evasion by inducing IL-10 | Nagamatsu et al.
(Fig. 3 C). In addition, we measured the release of lactate   
dehydrogenase (LDH) into the extracellular medium from 
the infected cells (Fig. 3 D). BopC and T3SS (unpub-
lished data) elicited no cytotoxicity in the infected DC2.4 
cells. In contrast, infection with WT or BopN produced 
increased frequency of unciliated cells, and infiltration of in-
flammatory  cells  and  erythrocytes  upon  BopN  infection 
(Fig. 3 B, arrows). To eliminate the possibility that BopN is 
involved in the cytotoxic phenotype, DC2.4 cells were in-
fected with Bordetella and examined under a light microscope 
Figure 2.  BopN is required for disease process. (A) C57BL/6J mice (n = 27 for each group) were infected intranasally with 5 × 106 B. bronchiseptica WT, 
bopN, or T3SS, and the survival was monitored for 8 d after infection. ***, P < 0.0001 using the log-rank test. (B) Mice (n = 15 for each group) infected 
intranasally with the specified strains (5 × 105 bacteria) were sacrificed at the indicated days after infection. Lung specimens were homogenized and plated 
on BG agar plates. Colonies were counted to determine the number of colonized bacteria per lung. The values are means ± SD from three independent ex-
periments. *, P < 0.05. (C and D) Mice (n = 9 for each group) infected intranasally with the indicated strains (5 × 105 bacteria) were sacrificed, and cells were 
isolated from the whole lung. The total numbers of neutrophils (C) or macrophages (D) in the lung were determined by FACS analysis. The values are means 
± SE from three independent experiments. *, P < 0.05. (E and F) The total number of neutrophils or macrophages in the lung obtained from C or D, respec-
tively, was normalized by the bacterial number in the lung obtained from B. The values are means ± SE from three independent experiments. (G) 2 d after 
infection (5 × 105 bacteria), lung sections were fixed and stained with H&E. The infiltration of neutrophils and macrophages into the pulmonary alveoli and 
peribronchiolar edema formation are observed in mice infected with WT, bopN, and T3SS. Arrows indicate bronchioles. The number of neutrophils per 
100 µm2 was determined in three randomly obtained images of pulmonary alveoli. The area of the enlarged boxes corresponds to 8 µm2. Bar, 100 µm.JEM VOL. 206, December 21, 2009 
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Up-regulation of IL-10 benefits Bordetella
We have clearly demonstrated that BopN is involved in the 
up-regulation of IL-10 in infected DC2.4 cells (Fig. 1) and 
that this effector is an essential virulence factor that subverts 
the host immune system (Fig. 2 and Fig. 3). To further inves-
tigate the role of BopN in vivo, mice were infected intranasally 
similar cytotoxic effects, indicating that BopN is not involved 
in the cytotoxic phenotype. These results are consistent with 
the hypothesis that BopN functions as an immunosuppressive 
modulator to down-regulate the host inflammatory responses. 
Thus, Bordetella has the ability to alter the tracheal microen-
vironment for its own benefit by exploitation of BopN.
Figure 3.  BopN suppresses inflammatory responses at the bacterial-colonized area. (A and B) Scanning electron micrographs of mouse tracheas 
infected with WT (A) and BopN Bordetella (B). C57BL/6J mice were infected intranasally with 5 × 106 WT and BopN B. bronchiseptica, and tracheal  
sections were obtained 2 d after infection. Arrowheads indicate bacteria. Arrows indicate erythrocytes and inflammatory cells. Note that extensive  
cell-surface disruption, including increased unciliated cells as well as infiltration of inflammatory cells and erythrocytes, is observed in mice infected  
with BopN but not WT. The areas of the enlarged boxes correspond to 20 µm2 (top) and 4 µm2 (bottom). Bars: (top and middle) 10 µm; (bottom) 1 µm. 
(C) DC2.4 cells were infected with the indicated strains (m.o.i. = 10) for 60, 120, and 180 min and then analyzed with Nomarski imaging. Both WT and 
BopN induced significant morphological changes, including rounding and detachment, in the cells. Bar, 20 µm. (D) Time course of the release of LDH 
into the extracellular medium from DC2.4 cells infected with the indicated strains. The values are the percentages of LDH released from Triton X-100–
lysed DC2.4 cells after subtraction of the value measured in uninfected cells. Error bars represent means ± SE from triplicate experiments. The amounts 
of LDH released after BopN infection were similar to those released after WT infection.3078 Bordetella immune evasion by inducing IL-10 | Nagamatsu et al.
was found comparing WT and BopN infection in IL-10/ 
mice; large amounts of IFN- were produced in the lungs of 
IL-10/ mice upon infection with either WT or BopN 
(Fig. 4 D). This genetic evidence indicates that the major in 
vivo target of BopN is indeed the regulation of IL-10 pro-
duction and that BopN exploits IL-10 to establish persistent 
colonization during Bordetella infection.
CD11c+ cells are recruited into pulmonary alveoli  
during Bordetella infection
IL-10 production by DCs and macrophages is essential for 
the control of excessive inflammatory responses. Our study 
demonstrated that the disease process of Bordetella infection 
involves the function of BopN in IL-10 up-regulation. To 
further confirm whether Bordetella exploits IL-10–producing 
cells  during  infection,  we  performed  immunostaining  on 
lung sections obtained from mice infected with WT or 
BopN Bordetella. Immunostaining for CD11c, one of the 
main surface antigens present in DCs or macrophages (Fig. 5 A), 
showed extensive recruitment of CD11c+ cells into the 
pulmonary  alveoli  of  WT  Bordetella-infected  lung  tissues.   
A similar observation was obtained using BopN-infected 
tissue, suggesting that the absence of BopN does not affect 
CD11c+ cell recruitment to the lung. We also determined 
the number of CD11c+ cells in the lung by FACS analysis 
(Fig. 5 B). Again, the total number of CD11c+ cells in the 
with WT B. bronchiseptica or a mutant strain, and the amounts 
of the cytokine produced were determined by ELISA on ho-
mogenized lung specimens (Fig. 4, A and B). The production 
of the antiinflammatory cytokine IL-10 in the lungs of mice 
infected with WT was significantly higher than that in the 
lungs of mice infected with BopN or T3SS on day 2 or 5 
(Fig. 4 A). In contrast, the production of the inflammatory 
cytokine IFN- in mice infected with WT was significantly 
lower than that of mice infected with BopN or T3SS 
(Fig. 4 B). These results clearly indicate that BopN is in-
volved in the up-regulation of IL-10 production in vivo, 
thereby leading to the inhibition of IFN- production.
To further investigate whether the major biological target 
of BopN in the pathophysiology of Bordetella infection is 
the up-regulation of IL-10, WT and IL-10/ mice were 
infected intranasally with WT or BopN B. bronchiseptica.   
As expected (Skinner et al., 2005), WT Bordetella colonization 
in IL-10/ mice was significantly decreased compared with 
that in C57BL/6J mice 2 d after infection (Fig. 4 C). Impor-
tantly, although the colonization by WT Bordetella was sig-
nificantly higher than that of BopN in C57BL/6J mice, no 
significant difference was found between WT and BopN 
colonization in IL-10/ mice (Fig. 4 C). In addition, al-
though the production of IFN- in the lungs of C57BL/6J 
mice infected with WT Bordetella was significantly lower than 
that of mice infected with BopN, no significant difference 
Figure 4.  BopN induces IL-10 production in vivo. (A and B) Detection of IL-10 (A) or IFN- (B) production in Bordetella-infected mice is shown. 
C57BL/6J mice (n = 9 for each group) were infected intranasally with 5 × 105 B. bronchiseptica. Homogenized lung specimens were prepared from mice 
infected with the indicated strains at 2, 5, or 8 d after infection, and the amounts of cytokines in the specimens were determined by ELISA. (C) C57BL/6J 
(WT) or IL-10/ mice (n = 3 for each group) on a C57BL/6J background were infected intranasally with the indicated strains (5 × 105 bacteria). 2 d after 
infection, lung specimens were homogenized and plated on BG agar plates to detect the number of colonizing bacteria. (D) IFN- production in the lungs 
of Bordetella-infected mice (n = 3 for each group). Homogenized lung specimens were prepared and the amounts of cytokines were determined by ELISA. 
The values are means ± SE from three independent experiments. *, P < 0.05.JEM VOL. 206, December 21, 2009 
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by the BopN preinfection (Fig. 6 B). Furthermore, the   
up-regulation of IL-10 production by WT Bordetella was 
disturbed by preinfection with BopN (Fig. 6 C), and the 
production of IFN- in mice preinfected with BopN was 
significantly higher than that of mice undergoing mock pre-
infection (Fig. 6 D). Collectively, these results confirm that 
the up-regulation of IL-10 by the BopN effector, resulting in 
the suppression of IFN- signaling, is a significant stealth 
strategy by which Bordetella evades the host immune system.
BopN regulates the mitogen-activated protein kinase 
(MAPK) signaling pathways
Infection with B. bronchiseptica triggers the down-regulation 
(dephosphorylation) of MAPKs (Reissinger et al., 2005) in   
a T3SS-dependent manner. To examine whether the BopN 
effector is involved in MAPK signaling alterations, we as-
sessed MAPK signaling in DC2.4 cells infected with Bordetella 
by immunoblot analysis using phosphospecific anti-p38, 
anti–extracellular  signal-regulated  kinase  (ERK)  1  and   
–ERK2, or anti–c-Jun N-terminal kinase (JNK) antibodies 
(Fig. 7 A). Band intensities of the phosphorylated and total 
MAPK products were quantified using the ImageJ applica-
tion (Fig. S2 A). At 30 min after infection, the amounts of 
phospho-p38 in DC2.4 cells infected with WT were signifi-
cantly lower than those in DC2.4 cells infected with BopN 
or  T3SS.  Similarly,  the  level  of  phosphorylated  (active) 
lung of mice infected with WT was similar to that in the lung 
of mice infected with BopN (Fig. 5 B). However, the 
percentage of IL-10+ CD11c+ cells in the lung upon WT 
infection  was  significantly  higher  than  that  in  the  lung 
upon BopN infection (Fig. 5, C and D). Collectively, 
these  results  indicate  that  Bordetella  allows  recruitment  of 
CD11c+ cells during infection, thus leading to the up-regulation 
of IL-10 production by BopN.
Preinfection with BopN allows mice to survive  
a lethal dose of Bordetella
Our in vitro and in vivo data led us to hypothesize that if 
mice were pretreated with BopN, which allows strong host 
inflammatory responses, they might be able to survive a sub-
sequent lethal dose of Bordetella WT bacteria. Hence, we per-
formed a successive infection study (Fig. 6). C57BL/6J mice 
were infected intranasally with BopN (5 × 105 bacteria) or 
PBS (mock preinfection) 24 h before WT Bordetella infection 
(9 × 105 bacteria). As shown in Fig. 6 A, although all mice 
with mock preinfection were killed by a lethal dose of WT 
bacteria, 24 out of 27 mice preinfected with BopN survived 
the WT infection. The in vivo successive infection study 
clearly demonstrates that preinduction of host inflammatory 
responses by an avirulent BopN strain contributes to sur-
vival of the mice upon a lethal dose of WT Bordetella. Indeed, 
the number of bacteria in the lung was greatly decreased 
Figure 5.  CD11c+ cells migrate into the lung and produce IL-10 during Bordetella infection. (A) C57BL/6J mice were infected intranasally with  
5 × 105 WT or BopN B. bronchiseptica. 2 d after infection, lung sections were immunostained with anti-CD11c monoclonal antibodies (brown). Note that 
extensive recruitment of CD11c+ cells into the pulmonary alveoli was observed in mice infected with WT and BopN. Bar, 50 µm. (B) 2 d after infection, 
the total numbers of CD11c+ cells in the lungs of mice (n = 3 for each group) infected with the indicated strains were determined by FACS analysis.  
(C) The lung cells from mice (n = 3 for each group) infected with Bordetella were pooled, stained with FITC-conjugated anti–IL-10 and PE-conjugated 
anti-CD11c, and determined by FACS analysis (percentages are shown). (D) The histogram shows the results obtained in C expressed as a ratio of IL-10+/CD11c+ 
cells. The values in B and D are means ± SE from three independent experiments. *, P < 0.05.3080 Bordetella immune evasion by inducing IL-10 | Nagamatsu et al.
were treated with the specific MEK1/2 inhibitor U0126 
(Fig. 7 C). We assessed the activity of the MEK1/2 and 
MKK3/MKK6 signaling by immunoblotting (Fig. 7 D). The 
amounts of phospho-MEK1/2 and phospho-MKK3/MKK6 
in DC2.4 cells infected with WT were lower than those in 
DC2.4 cells infected with BopN or T3SS (Fig. 7 D).
To  characterize  the  transcription  factors  affected  by 
BopN, nuclear extracts were prepared from DC2.4 cells   
infected with WT, bopN, and T3SS Bordetella, and tran-
scription factor activities were analyzed using a Multiplex 
transcription  factor  profiling  kit.  The  level  of  AP-1  and 
CREB activation in DC2.4 cells was significantly reduced   
after infection with WT relative to BopN infection (Fig. 7 E).   
These observations were consistent with the fact that MAPK 
signaling is down-regulated by the function of BopN, be-
cause both AP-1 and CREB transcription factors are down-
stream of MAPKs. Collectively, BopN down-regulates both 
MAPK kinase and MAPK signaling pathways.
BopN regulates the NF-B signaling pathways
It has also been reported that NF-B pathways are modulated 
during B. bronchiseptica infection (Yuk et al., 2000). There-
fore, the translocation of NF-B into the nucleus was inves-
tigated  using  DC2.4  cells  infected  with  Bordetella.  DC2.4 
cells were infected with WT or BopN for 20 min and then 
fixed and permeabilized. NF-B translocation was analyzed 
by immunofluorescence microscopy using anti–NF-Bp65 
or anti–NF-Bp50 antibodies (Fig. 8, A and B). As expected 
(Yuk et al., 2000), the translocation of NF-Bp65 into nuclei 
was inhibited by WT B. bronchiseptica infection (Fig. 8 A). 
In contrast, the nuclear translocation of NF-Bp65 was intact 
in the absence of BopN (Fig. 8 A, BopN). The difference 
in NF-Bp65 translocation into nuclei between WT and 
BopN infection was statistically significant (Fig. 8 C). Con-
versely,  the  nuclear  translocation  of  NF-Bp50  observed   
after WT infection was significantly blocked in the absence 
of BopN (Fig. 8, B and C). To further confirm the subcellular 
distribution of NF-B, DC2.4 cells infected with Bordetella 
for 30 min were separated into nuclear and cytosolic frac-
tions. The resulting fractions were subjected to immunoblot 
analysis using anti–NF-Bp65 and anti–NF-Bp50 antibod-
ies (Fig. 8 D). NF-Bp65 translocation into nuclei was greatly 
inhibited by WT Bordetella infection. In contrast, NF-Bp65 
was detected in the nuclear fraction of DC2.4 cells infected 
with BopN or T3SS. Conversely, the nuclear transloca-
tion of NF-Bp50 observed after WT infection was largely 
blocked in the absence of BopN (Fig. 8 D). Thus, BopN 
participates in altering the nuclear compartmentalization of 
NF-B p65 and p50 subunits.
Inhibition of inhibitor of NF-B (IB) degradation by a 
bacterial effector is one bacterial strategy to prevent NF-B 
translocation into nuclei (see Discussion). To determine if 
BopN is involved in the inhibition of IB degradation, 
DC2.4 cells were stimulated with 10 µg/ml LPS or infected 
with WT, BopN, and T3SS B. bronchiseptica, and the cell 
lysates were analyzed using immunoblotting with anti-IB, 
ERK2 and JNK in DC2.4 cells infected with WT was lower 
than that in BopN or T3SS (Fig. 7 A and Fig. S2 A). To 
further confirm the down-regulation of MAPK signaling by 
BopN, we assessed the subcellular localization of ERK after 
Bordetella  infection  and  compared  the  localization  of  total 
ERK with that of active phosphorylated ERK (Fig. 7 B). The 
specificity  of  phospho-ERK  antibodies  was  also  confirmed   
by pretreatment of cells with a specific MEK1/2 inhibitor, 
U0126 (Fig. S2 B). In addition, we determined the percent-
ages of cells showing phosphorylated ERK (Fig. S2 C). The 
number of cells showing phosphorylated ERK was signifi-
cantly decreased in WT infection relative to BopN infec-
tion. These results clearly indicate that BopN is involved in 
the down-regulation of MAPKs. To examine the relation-
ship  between  the  down-regulation  of  MAPKs  and  IL-10 
production, MAPK inhibitors were used (Fig. 7 C). Inhibi-
tion of the p38 pathway with a specific inhibitor, SB203580, 
did not greatly affect the level of IL-10 mRNA expression. 
However,  the  level  of  IL-10  mRNA  was  significantly   
increased in DC2.4 cells infected with BopN when DCs 
Figure 6.  In vivo successive infection study. (A) C57BL/6J mice  
(n = 27 for WT + PBS and WT + BopN) were infected intranasally with 
5 × 105 BopN or PBS (mock infection) 24 h before infection with a  
lethal dose of WT Bordetella (9 × 105), and the survival was monitored 
for 8 d. **, P < 0.005 using the log-rank test. (B) 2 d after the WT lethal-
dose infection, the lung specimens of mice (n = 3 for WT + PBS preinfec-
tion and WT + BopN preinfection) were homogenized and plated on  
BG agar plates to detect the number of colonized bacteria. (C and D) 2 d 
after the WT lethal-dose infection, homogenized lung specimens were 
prepared from mice (n = 3 for WT + PBS and WT + BopN) infected  
with the indicated strains, and the amount of IL-10 (C) or IFN- (D) in 
the specimen was determined by ELISA. The values in B–D are means  
± SD from three independent experiments. *, P < 0.05.JEM VOL. 206, December 21, 2009 
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detected  in  the  nuclei  of  DC2.4  cells  infected  with  WT   
Bordetella in the presence of leptomycin B (unpublished data). 
Conversely, the amounts of nuclear NF-Bp50 in DC2.4 
cells infected with WT Bordetella were somewhat reduced in 
the presence of leptomycin B. In contrast to WT infection, 
localization of neither NF-B p65 nor p50 in DC2.4 cells   
infected with BopN was affected by leptomycin B (unpub-
lished data). Thus, altered NF-B translocation may contrib-
ute to the effects of BopN on the up-regulation of IL-10.
BopN alone modulates nuclear NF-B subunit 
compartmentalization and down-regulates MAPK signaling
To analyze the precise function of BopN in the process of 
NF-B nuclear translocation, we constructed expression vec-
tors for the production of BopN fused with a Myc-tag, BopN 
anti-IB,  anti-IB,  and  anti–NF-Bp105  antibodies 
(Fig. 8 E). Degradation of IB was detected in DC2.4 cells 
infected with WT and BopN B. bronchiseptica. In contrast, 
degradation of IB, IB, and NF-Bp105 was not de-
tected during Bordetella infection. Thus, IB degradation is 
triggered by Bordetella infection, but this event is independent 
of BopN function.
To investigate whether the nuclear export of proteins, 
such as NF-B, is involved in Bordetella infection–induced 
IL-10 production, DC2.4 cells were treated with leptomycin 
B, an inhibitor of nuclear export, and then infected with WT 
or BopN (Fig. 8 F). The enhanced production of IL-10   
in DC2.4 cells infected with WT Bordetella was significantly 
reduced in the presence of leptomycin B. Immunofluores-
cence microscopy analyses showed that NF-Bp65 could be 
Figure 7.  Molecular characterization of the function of BopN in MAPK pathways. (A) Immunoblot analysis of MAPK activities in the lysates of DC2.4 
cells. DC2.4 cells were stimulated with 10 µg/ml LPS or infected with the indicated Bordetella strains for the specified time periods. The lysates were analyzed 
by Western blotting with antibodies against phospho-p38 (top), phospho-ERK1/2 (third from top), and phospho-JNK (fifth from top). The membranes were 
stripped and reblotted with antibodies against p38 (second panel), ERK1/2 (fourth from top), and JNK (bottom). (B) Immunofluorescence microscopy of DC2.4 
cells stimulated with LPS for 30 min or infected for 30 min with the indicated strains. DC2.4 cells were fixed and stained with anti–phospho-ERK1/2 (green), 
anti-ERK1/2 (red), and DAPI (blue). Data are representative of three independent experiments. Bar, 20 µm. (C) 10 µM of MEK1/2 inhibitor U0126, 50 µM of p38 
kinase inhibitor SB203580, and vehicle control (DMSO) were added to DC2.4 culture medium for 1 h before infection (m.o.i. = 100) with the indicated strains. 
Total RNA was prepared from the treated cells, and the amounts of IL-10 mRNA produced were assessed by qRT-PCR. (D) DC2.4 cells were infected with the 
indicated strains (m.o.i. = 100) for the specified time periods, and the amounts of phospho-MEK1/2 and phospho-MKK3/MKK6 were analyzed using immuno-
blotting. Three independent experiments were performed and a representative immunoblot is shown. (E) DC2.4 cells were stimulated with 10 µg/ml LPS or 
infected with the indicated strains for 30 min, and nuclear fractions were prepared and analyzed using a Multiplex transcription factor profiling kit. Differ-
ences in transcription factor activation were determined by Bio-Plex. The values in C and E are means ± SE from three independent experiments. *, P < 0.05.3082 Bordetella immune evasion by inducing IL-10 | Nagamatsu et al.
nuclear translocation. In contrast to NF-Bp65, most of the 
NF-Bp50 was localized in the cytosol of control Cos7 cells   
(vector alone), but translocation of NF-Bp50 into nuclei 
was facilitated by introduction of pBopN-FL (Fig. 9, A–C). 
Similar observations were obtained upon introduction of 
pBopN-FL into a macrophage cell line, RAW264.7, and   
nuclear translocation of BopN was detected in the presence 
full length (pBopN-FL; aa 1–365), BopN N-terminal half 
(pBopN-NT; aa 1–182), and BopN C-terminal half (pBopN-
CT; aa 182–365), and the resulting constructs were intro-
duced  into  Cos7  cells  (Fig.  9,  A–C).  Interestingly,  the 
N-terminal  half  (aa  1–182)  of  BopN  was  sufficient  for   
the translocation of BopN into the nucleus, although the C-
terminal half was required to completely block NF-Bp65 
Figure 8.  Molecular characterization of the mechanism by which BopN affects NF-B pathways. (A and B) Immunofluorescence microscopy  
of DC2.4 cells 30 min after stimulation with 10 µg/ml LPS or infection with WT or BopN Bordetella (m.o.i. = 100). The cells were stained with anti– 
B. bronchiseptica antibodies (red), anti–NF-Bp65 (A, green), or NF-Bp50 (B, green) antibodies, and DAPI for nuclei (blue). Bars, 10 µm. (C) DC2.4 cells 
infected with WT or BopN Bordetella were randomly picked from the immunofluorescence micrographs (A and B), and the percentages of cells showing 
nuclear translocation of NF-Bp65 (left) or NF-Bp50 (right) were determined. Percentages were based on a count of 50 cells, and the values are means 
± SD from three independent experiments. *, P < 0.05. (D) DC2.4 cells were stimulated by 10 µg/ml LPS or infected with the indicated strains for 30 min, 
and then separated into nuclear and cytosolic fractions. The resulting fractions were subjected to immunoblot analyses using anti–NF-Bp65 and anti–
NF-Bp50 antibodies. Histone H3 antibodies were used as a nuclear control. The majority of both p65 and p50 was localized in the cytoplasm (A, B, and D)  
of unstimulated cells. (E) Immunoblot analysis of IB, IB, IB, or NF-Bp105 in the lysates of DC2.4 cells. DC2.4 cells were stimulated with 10 µg/ml 
LPS or infected with the indicated strains, and total cell lysates were analyzed using immunoblotting with anti-IB, anti-IB, anti-IB, or anti–NF-
Bp105 antibodies. (F) 20 nM leptomycin B, an inhibitor of nuclear export, or vehicle control (DMSO) was added to DC2.4 culture medium for 24 h before  
infection with the indicated strains. Total RNA was prepared from DC2.4 cells, and amounts of IL-10 mRNA were assessed by qRT-PCR. The values are  
means ± SE from three independent experiments. *, P < 0.05.JEM VOL. 206, December 21, 2009 
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of pBopN-FL into RAW264.7 cells. Interestingly, the level 
of IL-10 mRNA was significantly increased by introduction 
of pBopN-FL into RAW264.7 cells (Fig. 9 E). These results 
clearly indicate that BopN alone has an ability to induce IL-10 
production by down-regulation of the MAPK signaling path-
ways. To eliminate the possibility that the enhanced produc-
tion of IL-10 down-regulates MAPKs, IL-10/–BMDCs 
were infected with WT or BopN Bordetella and alterations   
in  MAPKs  were  detected  with  immunoblotting  (Fig.  S4). 
During Bordetella infection, the levels of active or inactive 
or absence of LPS (Fig. S3). Collectively, our results show 
that BopN has the ability to translocate itself into the nucleus 
and promotes nuclear translocation of NF-Bp50.
To further investigate whether BopN is directly involved 
in the down-regulation of MAPK signaling, pBopN-FL was 
introduced into RAW264.7 cells and MAPK activity was   
analyzed by immunoblotting (Fig. 9 D). The amounts of 
phospho-ERK2 and phospho-p38 in RAW264.7 were in-
creased by LPS stimulation. However, the activation (phos-
phorylation) of both MAPKs was reduced by the introduction 
Figure 9.  BopN alters the nuclear compartmentalization of NF-B. (A and B) A mammalian expression vector, pcDNA3.1/His(-)A, encoding the 
full-length BopN-FL (aa 1–365) or truncated versions of BopN (-NT, aa 1–182; -CT, aa 182–365) with a Myc-tag fused at its C terminus was introduced 
into Cos7 cells. 24 h after transfection, cells were stimulated with 10 µg/ml LPS for 10 min, and then fixed and stained with anti-Myc antibodies to detect 
BopN (green), anti–NF-Bp65 (A, red), or NF-Bp50 (B, red), and DAPI for nuclei (blue). Bars, 20 µm. (C) Schematic diagrams of BopN fusion constructs 
with a Myc-tag (green) used in translocation assays (A and B). aa numbers of full-length and truncated BopN are shown. (D) The pBopN-FL was intro-
duced into RAW264.7 cells. After LPS stimulation for 30 min, BopN-Myc fusion protein and phospho-MAPKs were detected by immunoblot analysis (left). 
Band intensity of phospho-ERK2 and phospho-p38 were quantified by the ImageJ application (right). The percentages of phospho-MAPK/total MAPK 
were determined from three independent experiments. (E) The level of IL-10 mRNA in RAW264.7 cells transfected with pBopN-FL was measured by  
qRT-PCR. The values presented for D and E are means ± SE from three independent experiments. *, P < 0.05.3084 Bordetella immune evasion by inducing IL-10 | Nagamatsu et al.
for specific phosphatases (Zhang, 2002). The precise mecha-
nism by which MAPK is inactivated is unclear, but this signal-
ing pathway is a target of BopN function (Fig. 7 and Fig. 9).
We have shown that Bordatella evades the host immune 
system and establishes persistent colonization via induction   
of IL-10. In general, ERK activation is required for host cells 
to produce high IL-10. However, our results clearly indicate 
that blockade of the ERK pathway by the specific MEK   
inhibitor U0126 allowed enhanced production of IL-10 in 
DC2.4 cells infected with BopN (Fig. 7 C). In contrast, 
pharmacological blockade of p38 activation does not affect 
IL-10 induction. Although the functional significance of altered 
JNK activation is still unclear, these results suggest that BopN 
regulation of IL-10 is mediated, at least in part, by its ability 
to modulate ERK activation.
The transcription factor NF-B, which consists of homo- 
and heterodimers of the p50, p52, p65 (also called RelA), 
RelB, and c-Rel subunits, plays a central role in regulating 
host immune and inflammatory responses (Baldwin, 1996; 
Ghosh et al., 1998; Karin and Ben-Neriah, 2000). In unstim-
ulated cells, NF-B is associated with members of the IB 
protein family in the cytoplasm as an inactive form. When a   
bacterial pathogen enters the host, various stimuli are de-
tected by Toll-like receptors (TLRs) and nucleotide-binding   
oligomerization domain protein–like receptors. These signal-
ing pathways trigger activation of the IB kinase to phos-
phorylate IBs, leading to ubiquitination of phospho-IBs 
and their degradation via the ubiquitin–proteasome pathway, 
thus permitting nuclear translocation of NF-B. (Sun and   
Ley, 2008). Nuclear NF-B activates the expression of   
immunoregulatory genes, including IFN-, as well as several 
other proinflammatory cytokines. Expression of these genes 
is required for the triggering of inflammatory responses   
that eliminate bacterial pathogens by innate immunity. The 
subversion  of  the  NF-B  signaling  pathway  is  a  bacterial 
mechanism by which to evade the host immune system. For 
example, Shigella OspG effector associates with ubiquitin-
conjugating enzymes that ubiquitinate phospho-IB, thus 
blocking NF-B translocation into nuclei (Kim et al., 2005). 
We showed that IB degradation is not affected by BopN 
function (Fig. 8 E). Furthermore, although OspG must be 
located in the host cytosol to exert its effects on degradation 
of phospho-IB, our data clearly showed that the BopN   
effector has the ability to independently translocate itself into 
the nucleus and contains a nuclear localization signal located 
in the N-terminal half (aa 1–182; Fig. 9). It has been reported 
that Bordetella inhibits the nuclear translocation of NF-Bp65 
in a T3SS-dependent manner (Yuk et al., 2000). In this study, 
we  showed  that  BopN  blocks  nuclear  translocation  of   
NF-Bp65 and promotes nuclear translocation of NF-Bp50. 
The translocation of NF-Bp50 into the nucleus is involved 
in  the  up-regulation  of  IL-10,  as  previously  described 
(Driessler et al., 2004; Cao et al., 2006). As shown in Fig. 8 F, 
leptomycin B inhibits IL-10 production, suggesting that the 
relocation of NF-B components contributes to the effects 
of BopN on IL-10 production.
MAPKs in IL-10/–BMDCs were similar to those in WT-
BMDCs,  and  the  down-regulation  of  MAPK  signaling  by 
BopN also occurred in the absence of IL-10. These results sug-
gest that altered MAPK activation can be attributed to BopN 
function and not to the enhanced production of IL-10.
DISCUSSION
BopN has long been thought to be a regulator for the Bordetella 
T3SS, because BopN shows weak homology (19%) to Yersinia 
YopN, which functions as a regulator to block secretion   
of Yop effectors (Forsberg et al., 1991). Secretion of Yop   
effectors via the T3SS is induced by contact between the bac-
terium and the host cell. In vitro, Yop secretion is dependent 
on calcium, being blocked in the presence and induced in the 
absence of calcium (Michiels et al., 1990). The block of Yop 
secretion in the presence of calcium requires a functional 
YopN; YopN deficiency results in constitutive secretion of Yop 
proteins in the presence or absence of calcium and before 
contact with the host cell (Forsberg et al., 1991). In this study, 
we demonstrated that BopN is an effector protein but not a 
regulator of other Bop proteins, and that the BopN effector 
translocates itself into the nuclei of host cells and triggers the 
up-regulation of IL-10. This alters the microenvironment and 
allows Bordatella to escape from the host immune system. We 
also have confirmed that the Bordetella BopN-deficient strain 
does not affect secretion of other type III–secreted proteins 
during in vitro growth (unpublished data).
In B. bronchiseptica, the gene encoding BopN is located 
within the Bsc T3SS locus, and BopN in B. bronchiseptica 
shows extensive identity (99%) to the BopN of B. pertussis 
Tohama I and B. parapertussis 12822, suggesting that the 
function  of  BopN  is  probably  equivalent  throughout  the   
Bordetella species. To our knowledge, two effectors, BopC 
and BopN (this study), have been identified and characterized   
in B. bronchiseptica. The BopC effector induces necrotic cell 
death in infected cultured cells (Panina et al., 2005; Kuwae   
et al., 2006). However, as shown in Fig. 3 A, no histopath-
ological lesions, including disruption of ciliated cells, were 
detected in mice infected with WT B. bronchiseptica (BopC-
positive phenotype), suggesting that the respiratory tract is 
not a BopC target.
To evade the host immune system, certain bacterial patho-
gens have evolved strategies to subvert activation of host   
signaling pathways. For example, Shigella delivers OspF into 
the host cell via T3SS. This effector is translocated into the 
nucleus and dephosphorylates MAPKs, thereby preventing 
phosphorylation of histone H3 at Ser10 (Arbibe et al., 2007). 
Thus, epigenetic modification by the OspF effector results in 
inhibition of NF-B chromatin access leading to the inactiva-
tion of IL-8 and other genes essential for innate immune   
responses (Thomson et al., 1999; Saccani et al., 2002; Arbibe 
et al., 2007). Recently, OspF was characterized as a phos-
phothreonine lyase, which removes phosphate groups from 
the phosphothreonine residues of MAPKs (Li et al., 2007). 
However, BopN has no sequence similarity to OspF and does 
not contain His-Cys-X5-Arg-Ser/Thr, a catalytic active site JEM VOL. 206, December 21, 2009 
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(Sekiya et al., 2001) were used as the cloning and positive suicide vectors,   
respectively. A 2.4-kbp DNA fragment containing the bopN gene was   
amplified by PCR with the primers B1-bopN (5-AAAAAGCAGGCTCC-
GCCTGGGCCTCGGCCTCT-3) and B2-bopN (5-AGAAAGCTGGGT-
GCCAGGGCCAGCAGGGACC-3) using B. bronchiseptica S798 genomic 
DNA as the template. The resulting PCR product was cloned into pDONR201 
to obtain pDONR-bopN using the adaptor PCR method in the Gateway 
cloning system (Invitrogen). Inverse PCR was performed with the prim-
ers R1-bopN (5-GGAATTCATTGGGGGCGGCATCGATAC-3) and   
R2-bopN (5-GGAATTCAACGCGATAGCAATGGAGAA-3) using cir-
cular pDONR-bopN as the template. The underlined portions indicate the 
EcoRI sites. The resulting PCR products were digested with EcoRI and   
self-ligated to obtain pDONR-bopN, which contained a 1,044-bp dele-
tion within the open reading frame of bopN. pDONR-bopN was mixed   
with pABB-CRS2 to obtain pABB-bopN using the Gateway cloning sys-
tem. pABB-bopN was introduced into E. coli SM10pir and was transcon-
jugated into the B. bronchiseptica S798 (streptomycin resistant), as previously   
described (Donnenberg and Kaper, 1991). The resulting mutant strain was 
designated as B. bronchiseptica BopN. For the complementation of the bopN 
defect in BopN, pBopN was constructed as follows. A 1.2-kbp fragment 
encoding bopN was amplified by PCR with the primers B1-bopN–comp   
(5-AAAAAGCAGGCTGCGACACTCACTGCACCAGT-3) and B2-
bopN–comp  (5-AGAAAGCTGGGTATCCTGGCCGAACTGATGCA-3) 
using B. bronchiseptica S798 genomic DNA as the template. The resulting frag-
ment was cloned into pDONR201 and designated as pDONR-bopN–comp. To   
control the transcription of the bopN gene by the fha promoter and rrnB  
terminator in Bordetella, pDONR-fhaP (Kuwae et al., 2006), pDONR-bopN–
comp, pDONR-rrnB (Kuwae et al., 2006), and pRK415 R4-R3-F (Kuwae 
et al., 2006) were mixed and treated with LR Clonase Plus (Invitrogen) to 
clone the fha promoter, bopN, and rrnB terminator into pRK415 R4-
R3-F using the MultiSite Gateway system (Invitrogen), and the resulting 
plasmid was designated as pBopN. To express the BopN-Myc fusion pro-
tein in mammalian cells, pBopN-FL was constructed as follows. The bopN  
gene was amplified by PCR with the primers 5-GGAATTCGCCAC-
CATGGCTCGTATCGATGCCG-3 (forward) and 5-CGGGATCCT-
GCGTTCTCCATTGCTATCG-3 (reverse) using B. bronchiseptica S798   
genomic DNA as the template. To obtain the plasmid encoding truncated 
versions of the BopN-NT or BopN-CT, PCR was performed with the 
primer sets 5-GGAATTCGCCACCATGGCTCGTATCGATGCCG-3  
(forward) and 5-CGGGATCCCGCTTGCGCGGCCAGTTGC-3 (reverse)   
or  5-GGAATTCGCCACCATGGGTGTCACGCAGCAATACC-3  
(forward)  and  5-CGGGATCCTGCGTTCTCCATTGCTATCG-3  
(reverse). The underlined portions, GAATTC and GGATCC, indicate 
the EcoRI and BamHI sites, respectively. The EcoRI-BamHI fragment of 
the resulting PCR product was cloned into the EcoRI and BamHI sites of 
pcDNA3.1/His(-)A (Invitrogen) to obtain pBopN-FL, pBopN-NT, and 
pBopN-CT, respectively.
Mice. 5–6-wk-old C57BL/6J mice were purchased from Nihon SLC.   
IL-10/ mice on a C57BL/6J background were obtained from the Jackson 
Laboratory.
Cells and transfection. The DC line DC2.4 was provided by K.M. 
Rock (University of Massachusetts, Worcester, MA) and grown in RPMI 
1640  (Invitrogen)  containing  10%  FCS  (Sigma-Aldrich),  55  µM  2- 
mercaptoethanol, 100 U/ml penicillin, and 100 µg/ml streptomycin at 37°C 
under an atmosphere of 5% CO2. Cos7 cells (American Type Culture 
Collection)  were  maintained  in  Dulbecco’s  modified  Eagle’s  medium 
(Sigma-Aldrich)  with  10%  FCS.  The  mouse  macrophage  cell  line 
RAW264.7  (American  Type  Culture  Collection)  was  maintained  in 
RPMI 1640 medium with 10% FCS. Cos7 and RAW264.7 cells were   
transfected with 2.5 µg/ml pcDNA3.1/His(-)A, pBopN-FL, pBopN-NT, 
and pBopN-CT using Lipofectamine LTX (Invitrogen) according to the 
manufacturer’s protocol. After transfection, the cells were incubated at 
37°C for 24 h and fixed in 4% paraformaldehyde.
In Yersinia, LcrV is located at the tip of the T3SS needle 
structure (Mueller et al., 2005) and is involved in effector 
translocation. LcrV reportedly enhances production of IL-10 
via  association  with  TLR2  (Sing  et  al.,  2005).  However, 
TLR2/  mice  were  not  protected  against  subcutaneous 
plague infection (Pouliot et al., 2007). Recently, Depaolo   
et al. (2008) demonstrated that LcrV-mediated TLR6 is   
involved in the up-regulation of IL-10 via activation of the 
JNK pathway. They further confirmed that IL-10/ and 
TLR6/ mice are significantly protected from plague infec-
tion. Thus, both Bordetella and Yersinia species induce the   
up-regulation of IL-10, but they exploit different host-cell 
signaling pathways using different virulence factors.
We demonstrated that BopN has the ability to alter both 
MAPKs and the nuclear translocation of NF-B, resulting 
in activation or inactivation of various transcriptional factors. 
Furthermore, we confirmed that NF-B activation in DC2.4 
cells infected with BopN was similar to that of DC2.4 cells 
infected with WT (Fig. S5). To our surprise, the level of CRE-
ATF, Myc-Max, and SP-1 activation in DC2.4 cells was sig-
nificantly increased after infection with WT relative to BopN, 
even though, in general, activation of these transcription fac-
tors is dependent on MAPK signaling. SP-1 plays an important   
role in IL-10 transcription (Chanteux et al., 2007). Thus, 
Bordetella appears to exploit a transcription factor, SP-1, for the 
up-regulation of IL-10 during infection, although the BopN-
mediated signaling pathway remains to be fully elucidated.
Phagocytosed  B.  pertussis  bacteria  are  easily  killed  by 
neutrophils (Lenz et al., 2000) and IFN- production is re-
quired for Bordetella clearance from the lung (Pilione and 
Harvill, 2006). Our in vivo successive infection study di-
rectly  showed  that  IFN-  production  is  involved  in   
Bordetella clearance and that mice can survive a lethal dose   
of WT Bordetella when the up-regulation of IL-10, as a   
Bordetella strategy, was perturbed by preinfection with the 
avirulent BopN strain (Fig. 6). Recently, it was reported 
that the T3SS of B. pertussis is also involved in persistent col-
onization in mice and that, indeed, BopN was detected as a 
protein secreted via T3SS (Fennelly et al., 2008). Another 
study showed that B. pertussis can induce IL-10 production 
in BMDCs (McGuirk et al., 2002). Thus, the up-regulation 
of IL-10 by the BopN effector is likely a stealth strategy by 
which Bordetella establishes an immunosuppressive environ-
ment such that the resulting microenvironment is advanta-
geous for persistent colonization.
MATERIALS AND METHODS
Bacterial strains and plasmids. E. coli DH10B, MC1061, and SM10pir 
were used as hosts for the construction of various plasmids. The WT strain 
used in this study was B. bronchiseptica S798 (Kuwae et al., 2003). The type 
III secretion mutant (T3SS) and BopC mutant (BopC) were derived 
from S798 WT (Kuwae et al., 2003, 2006). The inoculum for liquid 
culture of Bordetella strains was prepared from fresh colonies grown on   
Bordet-Gengou (BG) agar, and these bacteria were cultured in Stainer-Scholte 
liquid medium at a starting A600 of 0.2 with vigorous shaking at 37°C 
for 18 h, as previously described (Cotter and Miller, 1994, 1997; Martínez 
de Tejada et al., 1996). The B. bronchiseptica strain BopN mutant (BopN) 
was  created  as  follows.  pDONR201  (Invitrogen)  and  pABB-CRS2   3086 Bordetella immune evasion by inducing IL-10 | Nagamatsu et al.
fusion proteins were stained with anti-Myc antibody (Santa Cruz Biotechnol-
ogy, Inc.) and Alexa Fluor 488 goat anti–mouse IgG (Invitrogen).
mRNA analysis by real-time PCR. DC2.4 cells were seeded in 24-well 
plates at 2.5 × 105 cells/well, incubated for 20 h, and infected with Bordetella 
strains at an m.o.i. of 10. After incubation for the times indicated in the 
figures, total RNA was isolated using an RNeasy Mini Kit (QIAGEN), 
and 5 µg RNA from each sample was reverse transcribed using oligo (dT) 
primers and Omniscript RT (QIAGEN). The resulting 5 µl cDNA was 
amplified by SYBR Premix Ex Taq (Takara Bio Inc.) using mouse IL-10 
primers and -actin primers in a LightCycler apparatus (Roche). Primer 
pairs specific for IL-10 (forward, 5-AGCTGGACAACATACTGCTA-3;   
reverse, 5-TGGGCCATGCTTCTCTG-3) and -actin (forward, 5-GT-
GGGCCGCTCTAGCCACCAA-3;  reverse,  5-TCTTTGATGTCAC-
GCACGATTTC-3) were used. The specificity was checked by analyzing 
the melting curves, and results were calculated using the comparative cycle 
threshold method, in which the amount of target mRNA is normalized to 
the internal control -actin and calculated in arbitrary units set to a value of 
1 for uninfected cells.
Cytokine detection. Lung specimens were homogenized as described in In 
vivo infection of mice, and concentrations of IL-10 or IFN- in the homog-
enates were determined by an ELISA development kit (DuoSet; R&D Sys-
tems). The absorbance of each well was determined using a plate reader 
(Biotrak II; GE Healthcare).
Immunoblotting. DC2.4 cells infected with B. bronchiseptica were washed 
with PBS and solubilized with SDS sample buffer. The resulting samples 
were sonicated and boiled for 5 min, separated by SDS-PAGE on a 10% gel, 
and transferred to polyvinylidene fluoride membranes (Millipore). Proteins 
were analyzed by immunoblotting with anti–phospho–p38 MAPK (Thr180/
Tyr182), anti–phospho–p44/p42 MAPK (Thr202/Tyr204; E10), anti–
phospho–stress-activated  protein  kinase  (SAPK)/JNK  (Thr183/Tyr185), 
anti–phospho-MEK1/2  (Ser217/221),  and  anti–phospho-MKK3/MKK6 
(Ser189/207)  antibodies  (Cell  Signaling  Technology).  Anti-IB,  anti-
IB, anti-IB, and anti–NF-Bp105 antibodies (Cell Signaling Technol-
ogy) were used to detect IB, IB, IB, and NF-Bp105, respectively. 
To ensure equal protein loading, the membrane was stripped and reprobed 
with  anti–p38  MAPK  (Santa  Cruz  Biotechnology,  Inc.),  anti–p44/p42 
MAPK, anti-SAPK/JNK, anti-MKK3, anti-MEK1/2 (47E6), or anti–-actin 
antibodies (Cell Signaling Technology). The detection of specific protein 
signals was performed using a detection kit (ECL; GE Healthcare). Nuclear 
and cytosolic fractions were prepared using a subcellular proteome extrac-
tion kit (ProteoExtract; EMD). Lysates of DC2.4 cells infected with B. bron-
chiseptica were separated into nuclear and cytosolic fractions, and the resulting 
fractions were analyzed by immunoblotting with anti–NF-Bp65 and anti–
NF-Bp50 (Santa Cruz Biotechnology, Inc.), and anti–histone H3 (Cell 
Signaling  Technology)  antibodies.  Protein  expression  levels  were  deter-
mined by densitometry analysis of immunoblots using ImageJ (version 1.42; 
National Institutes of Health).
Transcription  factor  profiling. Nuclear fractions were prepared from 
DC2.4 cells infected with B. bronchiseptica using the ProteoExtract subcellular 
proteome extraction kit and analyzed using a transcription factor profiling kit 
(Multiplex; Marligen). Positive binding of each transcription factor to the 
DNA probe was detected using Bio-Plex (Bio-Rad Laboratories).
Statistics. Statistical analyses were performed using the Mann-Whitney 
U test or the unpaired Student’s t test, with P < 0.05 considered statistically 
significant. Survival curves were generated by the Kaplan-Meier method, 
and statistical analyses were performed using the log-rank test.
Online  supplemental  material.  Fig.  S1  shows  H&E  staining  of  lung   
sections of mice infected with B. bronchiseptica. Fig. S2 shows densitometry 
analyses of immunoblots, immunofluorescence micrographs of MAPK   
Inhibitors. For the MAPK inhibition experiments, the MEK1/2 inhibitor 
U0126 (EMD) or the p38 kinase inhibitor SB203580 (EMD) was added to 
medium at 10 and 50 µM, respectively, for 1 h before LPS stimulation or 
Bordetella infection. To block nuclear export, leptomycin B (EMD) was 
added to medium at 20 nM for 24 h before the Bordetella infection.
Preparation of DCs from BM. BM cells prepared from the tibias and fe-
murs of mice were cultured at 1.5 × 106 cells/ml in RPMI 1640 medium 
with 10% FCS in the presence of 10 ng/ml GM-CSF (Fitzgerald Industries).   
BM cells were maintained for 3 d, and then one half of the medium was   
replaced by fresh medium. BM cells were further maintained for 3 d, and then 
DCs were purified using anti-CD11c microbeads with an autoMACS sepa-
ration system (Miltenyi Biotec) .
LDH assay. DC2.4 cells were seeded in 24-well plates at 2.5 × 105 cells/
well and incubated for 20 h. The precultured bacteria described in Bacterial 
strains and plasmids were added to the cells at a multiplicity of infection   
(m.o.i.) of 10 and centrifuged for 5 min. After incubation at 37°C under an 
atmosphere of 5% CO2 for the time periods indicated in the figures, the   
amounts of LDH were measured spectrophotometrically using a CytoTox 
96 Non-Radioactive Cytotoxicity Assay kit (Promega).
In vivo infection of mice. After arrival, all mice were housed for 1 wk 
before experiments. Mice were infected intranasally with 50 µl (5 × 106 or 
5 × 105 CFU) of a B. bronchiseptica overnight culture started from an individu-
ally isolated colony on BG agar plates. To determine the amount of bacterial 
colonization in the lung, the whole lung was homogenized in 10 ml of cold   
PBS using a digital homogenizer (Potter-Elvehjem; As One, Inc.). The   
resulting homogenates were serially diluted with cold PBS and plated on BG 
agar plates, and colonies were then counted to calculate the number of CFUs 
per mouse. For histological analysis, lung tissues were fixed in 4% parafor-
maldehyde in PBS and stained with H&E. For detection of DCs or macro-
phages  that  had  migrated  into  the  lung,  lung  tissues  were  fixed  and 
immunostained with anti-CD11c monoclonal antibodies (Endogen). For 
scanning electron microscopy observation, trachea sections were fixed in 
2.5% glutaraldehyde in PBS. Three 5–6-wk-old mice were used for each 
time point. All animal experiments were conducted according to protocols 
approved by the Experimental Animal Center of the Kitasato University.
Flow cytometry. Lung cells were incubated in 100 µl DMEM at 4°C for 
1 h and stained with PE-Cy7–conjugated anti–Gr-1 (clone RB6-8c5; eBiosci-
ence), FITC-conjugated anti-CD11b (clone M1/70; BD), and PE-conjugated 
anti-CD11c (clone HL3; BD). For ex vivo intracellular cytokine staining, 
lung cells were cultured at 37°C for 4.5 h in PBS supplemented with 2% FCS   
and GolgiStop (BD). Cells were stained with PE-conjugated anti-CD11c   
antibodies, and then fixed and permeabilized with Cytofix/Cytoperm solution 
(BD). After fixation and permeabilization, cells were stained with FITC-
conjugated anti–IL-10 (clone JES5-16E3; BD). Flow cytometric analysis (FACS) 
was performed with a multi–flow cytometry system (EPICS Elite; Beckman 
Coulter) using the EXPO 32 Elite software package (Beckman Coulter).
Fluorescence staining. DC2.4 cells were seeded in a 6-well plate at 5 × 105 
cells/well and incubated for 20 h, and then infected with Bordetella strains 
at an m.o.i. of 10. After 60 min, DCs were fixed for 15 min with 4% para-
formaldehyde in PBS and subjected to immunofluorescence staining with   
anti–NF-Bp65 and anti–NF-Bp50 antibodies (Santa Cruz Biotechnology, 
Inc.). As a secondary antibody, Alexa Fluor 488 goat anti–rabbit IgG (Invit-
rogen) was used. Nuclei were stained with DAPI (Invitrogen). Bacteria were 
visualized with rabbit anti–B. bronchiseptica serum (Denka Seiken) followed by 
Alexa Fluor 594–conjugated secondary antibody. Numbers of NF-Bp65 
translocated into nuclei were scored by examining 50 cells per coverslip under 
a fluorescence microscope. Phosphorylated or total ERKs were stained with 
anti–phospho-ERK or anti-ERK antibody (Cell Signaling Technology), and 
Alexa Fluor 488 goat anti–mouse IgG or Alexa Fluor 594 goat anti–rabbit 
IgG (Invitrogen) were used as secondary antibodies, respectively. BopN-Myc JEM VOL. 206, December 21, 2009 
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